Wilson Sonsini Goodrich & Rosati and Cooley advised Kura Oncology. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
Kura Oncology’s Collaboration with Kyowa Kirin
Jiangsu Hengrui Pharmaceuticals’ License Agreement With Elevar Therapeutics
Cooley advised Jiangsu Hengrui Pharmaceuticals on the deal. Jiangsu Hengrui Pharmaceuticals (“Hengrui”), a global pharmaceutical company focused on scientific and technological innovation, signed a global license agreement...
Jiangsu Hengrui Pharmaceuticals’ License Agreement With Merck
Cooley advised Jiangsu Hengrui Pharmaceuticals on the deal. Jiangsu Hengrui Pharmaceuticals (“Hengrui”), a global pharmaceutical company focused on scientific and technological innovation, announced its strategic collaboration...
Tenable’s $265 Million Acquisition of Ermetic
Cooley advised Tenable on the deal. Tenable Holdings, Inc. (Nasdaq: TENB) announced that it has signed a definitive agreement to acquire Ermetic Ltd. for a purchase...
TransMedics Group’s Acquisition of Organ Support and Heart Preservation Transport System Assets from Bridge to Life
Ropes & Gray acted as legal advisor to TransMedics, and Cooley acted as legal advisor to Bridge to Life. TransMedics Group, Inc. (Nasdaq: TMDX) announced that is...
Thirty Madison’s $32.3 Million Asset Purchase from The Pill Club
Cooley advised Thirty Madison on the deal. Thirty Madison announced that it will ensure continued care for over a hundred thousand patients after strategically acquiring assets,...
World View’s $350 Million Merger with Leo Holdings Corp. II.
Cooley advised World View on the deal. World View, a leader in stratospheric exploration and flight, announced its definitive business combination agreement with publicly traded special purpose...
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
Kite’s Acquisition of Tmunity
Cooley advised Tmunity on the deal. Tmunity, a clinical-stage biotechnology company, announced its agreement to sell to Kite, a global biopharmaceutical company. The acquisition will provide...
AstraZeneca’s Acquisition of Neogene Therapeutics
Cooley advised Neogene Therapeutics on the deal. Neogene Therapeutics, a global clinical-stage biotechnology company, signed its definitive agreement to be acquired by AstraZeneca for a total consideration...
Viatris’ Acquisition of Oyster Point Pharma
Cooley advised Oyster Point Pharma on the deal, while Cravath represented Viatris. Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, announced its definitive agreement to be acquired...
Ritchie Bros’ $7.3 Billion Acquisition of IAA, Inc.
Goodwin Procter, McCarthy Tétrault and Skadden, Arps, Slate, Meagher & Flom advised Ritchie Bros. Incorporated, while Cooley and Blake, Cassels & Graydon advised IAA on the...